Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
859.4 BRL | +1.29% | +5.82% | +37.09% |
07-02 | Baird Adjusts Price Target on Synopsys to $661 From $645, Maintains Outperform Rating | MT |
07-01 | Tech boom leads global markets through first half of 2024 | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 65.48 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+37.09% | 92.2B | - | ||
+16.31% | 85.24B | B+ | ||
+50.44% | 57.63B | D+ | ||
-22.01% | 48.6B | B+ | ||
+36.66% | 47.92B | D+ | ||
-23.37% | 46.4B | B- | ||
+73.68% | 39.85B | D+ | ||
-3.91% | 27B | C+ | ||
-18.77% | 23.72B | - | ||
+21.74% | 21.21B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SNPS Stock
- S1NP34 Stock
- Ratings Synopsys, Inc.